Long-term tracking of glycosylated hemoglobin levels across the lifespan in type 1 diabetes: from infants to young adults
Open Access
- 31 August 2024
- journal article
- research article
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 29 (4) , 242-249
Abstract
Purpose: Glycosylated hemoglobin (HbA1c) is commonly used as a monitoring tool in diabetes. Due to the potential influence of insulin resistance (IR), HbA1c level may fluctuate over a person's lifetime. This study explores the long-term tracking of HbA1c level in individuals diagnosed with type 1 diabetes mellitus (T1DM) from infancy to early adulthood.Methods: The HbA1c levels in 275 individuals (121 males, 43.8%) diagnosed with T1DM were tracked for an average of 9.4 years. The distribution of HbA1c levels was evaluated according to age with subgroups divided by gender, use of continuous glucose monitoring (CGM), and the presence of complications.Results: HbA1c levels were highest at the age of 1 year and then declined until age 4, followed by a significant increase, reaching a maximum at ages 15–16 years. The levels subsequently gradually decreased until early adulthood. This pattern was observed in both sexes, but it was more pronounced in females. Additionally, HbA1c levels were higher in CGM nonusers compared with CGM users; however, regardless of CGM usage, an age-dependent pattern was observed. Furthermore, diabetic complications occurred in 26.8% of individuals, and the age-dependent pattern was observed irrespective of diabetic complications, although HbA1c levels were higher in individuals with diabetic complications.Conclusion: HbA1c levels vary throughout the lifespan, with higher levels during adolescence. This trend is observed regardless of sex and CGM usage, potentially due to physiological IR observed during adolescence. Hence, physiological IR should be considered when interpretating HbA1c levels during adolescence.Keywords
This publication has 39 references indexed in Scilit:
- The global impact of COVID‐19 pandemic on the incidence of pediatric new‐onset type 1 diabetes and ketoacidosis: A systematic review and meta‐analysisJournal of Medical Virology, 2022
- Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysisDiabetologia, 2022
- Should continuous glucose monitoring systems be offered to all patients with type 1 diabetes mellitus?Irish Journal of Medical Science (1971 -), 2021
- Reference ranges of HOMA-IR in normal-weight and obese young CaucasiansActa Diabetologica, 2015
- Intensive glycemic control and cardiovascular disease: an updateNature Reviews Cardiology, 2010
- Metabolic control as reflectet by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decadeEuropean Journal of Pediatrics, 2007
- Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trialsAmerican Heart Journal, 2006
- Insulin resistance in type 1 diabetesDiabetes/Metabolism Research and Reviews, 2002
- Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications TrialThe Journal of Pediatrics, 1994
- Prevalence and development of retinopathy in children and adolescents with Type I (insulin-dependent) diabetes mellitus. A longitudinal studyDiabetologia, 1986